Silverarc Capital Management, LLC Bridge Bio Pharma, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$13.29 - $18.01 $132,900 - $180,100
10,000 Added 25.0%
50,000 $860,000
Q1 2023

May 15, 2023
BUY
$7.17 - $18.55 $286,800 - $742,000
40,000 New
40,000 $663,000
Q1 2022

May 13, 2022
SELL
$7.34 - $17.16 $734,000 - $1.72 Million
-100,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$11.38 - $53.41 $1.14 Million - $5.34 Million
100,000 New
100,000 $1.67 Million

Others Institutions Holding BBIO

# of Institutions
291
Shares Held
171M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email